Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) have received an average recommendation of "Buy" from the eight analysts that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, two have issued a buy rating and four have assigned a strong buy rating to the company.
A number of equities analysts have recently weighed in on RBGLY shares. Royal Bank Of Canada reiterated an "outperform" rating on shares of Reckitt Benckiser Group in a report on Friday, July 25th. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th.
Get Our Latest Stock Report on RBGLY
Reckitt Benckiser Group Price Performance
Shares of RBGLY opened at $14.99 on Thursday. The company has a quick ratio of 0.37, a current ratio of 0.56 and a debt-to-equity ratio of 1.01. Reckitt Benckiser Group has a 52-week low of $10.84 and a 52-week high of $15.25. The stock has a fifty day simple moving average of $14.16 and a two-hundred day simple moving average of $13.53.
Reckitt Benckiser Group Cuts Dividend
The firm also recently declared a dividend, which will be paid on Thursday, September 25th. Investors of record on Monday, August 11th will be paid a $0.2106 dividend. The ex-dividend date is Friday, August 8th. This represents a dividend yield of 341.0%.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.